Literature DB >> 10568001

Laminitis in the horse: a review.

M M Sloet van Oldruitenborgh-Oosterbaan1.   

Abstract

Laminitis has been a recognized disease since early Greek and Roman times, but it is still bothering both practitioners and scientists. In the last decade a lot of new fundamental research has been done to elucidate the pathogenesis of laminitis. New insights into the pathogenesis, the predisposing factors (including nutritional overload, endotoxaemia, shock, management, etcetera), clinical and radiological signs, differential diagnosis, therapy, and prognosis of the disease are described. The data, however, are not always in agreement with each other, giving further proof of the complexity of the syndrome.

Entities:  

Mesh:

Year:  1999        PMID: 10568001     DOI: 10.1080/01652176.1999.9695006

Source DB:  PubMed          Journal:  Vet Q        ISSN: 0165-2176            Impact factor:   3.320


  4 in total

1.  Prospective case-control study of toe tip necrosis syndrome (TTNS) in western Canadian feedlot cattle.

Authors:  Chad Paetsch; Kent Fenton; Tye Perrett; Eugene Janzen; Ted Clark; Jan Shearer; Murray Jelinski
Journal:  Can Vet J       Date:  2017-03       Impact factor: 1.008

2.  Management factors affecting stereotypies and body condition score in nonracing horses in Prince Edward Island.

Authors:  Julie L Christie; Caroline J Hewson; Christopher B Riley; Mary A McNiven; Ian R Dohoo; Luis A Bate
Journal:  Can Vet J       Date:  2006-02       Impact factor: 1.008

3.  Cloning and expression of ADAM-related metalloproteases in equine laminitis.

Authors:  Michael J Coyne; Hélène Cousin; John P Loftus; Philip J Johnson; James K Belknap; Carlos M Gradil; Samuel J Black; Dominique Alfandari
Journal:  Vet Immunol Immunopathol       Date:  2008-11-25       Impact factor: 2.046

4.  An investigation of the equine epidermal growth factor system during hyperinsulinemic laminitis.

Authors:  Melody A de Laat; Robert J Spence; Martin N Sillence; Christopher C Pollitt
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.